Breaking News

PerkinElmer Expands Reagent Portfolio

Uses AlphaLISA technology to help improve safety testing

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

PerkinElmer, Inc. has launched a new range of assay kits using AlphaLISA technology to help improve the safety testing, manufacturing and quality control of biotherapeutic drugs. PerkinElmer developed the new assays to help meet the stringent performance requirements relating to drug impurities and toxic effects.   According to the company, the AlphaLISA technology helps to achieve higher quality results than the comparable ELISA (enzyme-linked immunosorbent assay) technology in half the time, a...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters